Broadcom: The Market Has This One Wrong

Broadcom (AVGO) is reiterated as a strong buy despite a 15% decline since the prior coverage. The stock trades at ~19x 15-month forward P/E, about a 21% discount to the sector median, suggesting undervaluation. Expectations call for at least 60% growth in both top- and bottom-line over the next year, supported by AI demand and pricing power.

Analysis

The setup is less about the absolute multiple and more about whether the market is already capitalizing near-peak AI optimism. A 15% drawdown into a still-premium valuation can be attractive if earnings revisions stay positive, but the stock is only cheap relative to peers if the next two quarters confirm that AI-related revenue is broadening rather than just lapping an easy comp. In that sense, AVGO is a quality growth compounder whose rerating depends on the market believing the 60% growth path is durable, not a one-cycle burst.

The biggest second-order risk is not demand collapse; it is multiple compression from any sign that AI custom silicon, networking, or adjacent infrastructure spend is normalizing faster than expected. That matters because names tied to the AI supply chain tend to move together on guide quality: if AVGO misses even modestly, the read-through could hit other high-beta semiconductor winners first, while lower-growth analog and legacy networking suppliers may relatively outperform as investors rotate to safety. Conversely, if hyperscaler capex remains elevated, AVGO’s diversified cash flow should let it gain share versus more levered pure-play AI names.

The contrarian view is that consensus may be underestimating duration, not magnitude, of AI spend. If the market is too focused on near-term price action, it may be ignoring that AVGO’s combination of growth and cash generation can support multiple expansion once the next print validates the trajectory. Falsification is straightforward: any guide-down in AI-related demand, margin pressure from mix, or evidence that the 60% growth expectation has peaked would likely cap upside and invite a de-rating over the next 1-3 months.

Key Decisions for Investors

• Buy AVGO on further weakness or into a pre-earnings consolidation; the risk/reward improves if the stock remains below its recent downtrend and the next guide still implies >50% growth. Thesis breaks if management signals a material deceleration in AI demand or margin expansion.
• Pair trade: long AVGO / short SOXX for 1-3 months. Rationale: AVGO has a more visible AI monetization path and stronger cash conversion than the broader semi basket; the trade works if investors keep rewarding proven AI revenue and penalizing generic semiconductor exposure.
• If using options, prefer a call spread over outright calls into the next earnings catalyst to express upside from a rerating while limiting theta decay. This is most attractive if implied volatility remains elevated but not extreme.
• Alert level: if AVGO loses the prior support zone after the next earnings cycle and forward growth expectations roll down meaningfully, cut the position rather than averaging down. The stock can de-rate quickly if consensus revises the 60% growth story lower.